Barclays PLC Accelerate Diagnostics, Inc Put Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2018 Feb 14, 2019	SELL	$10.42 - $21.94 $1.82 Million - $3.83 Million	-174,400 Reduced 97.21%	5,000 $58,000
Q3 2018 Nov 14, 2018	BUY	$20.4 - $24.6 $726,240 - $875,760	35,600 Added 24.76%	179,400 $4.12 Million
Q2 2018 Aug 14, 2018	SELL	$19.02 - $24.95 $1.75 Million - $2.29 Million	-91,800 Reduced 38.96%	143,800 $3.21 Million
Q1 2018 May 15, 2018	BUY	$22.55 - $29.9 $2.98 Million - $3.95 Million	132,100 Added 127.63%	235,600 $5.38 Million
Q4 2017 Feb 14, 2018	BUY	$18.0 - $30.0 $595,800 - $993,000	33,100 Added 47.02%	103,500 $2.71 Million
Q3 2017 Nov 14, 2017	BUY	$21.1 - $25.15 $1.49 Million - $1.77 Million	70,400	70,400 $1.58 Million

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $168M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.